loader image
Friday, February 13, 2026
84.1 F
McAllen
- Advertisement -

DHR Health Begins a New Era of Residency Training in the RGV

Translate to Spanish or other 102 languages!

DHR Health is committed to remain the leader for GME in the Rio Grande Valley, as a health system and now as an independent ACGME-accredited sponsor for our future physicians’ training programs. Image Sources: Dr. Singh; Roberto Hugo Gonzalez, Bgd; DHR Health
DHR Health is committed to remain the leader for GME in the Rio Grande Valley, as a health system and now as an independent ACGME-accredited sponsor for our future physicians’ training programs. Image Sources: Dr. Singh; Roberto Hugo Gonzalez, Bgd; DHR Health

Mega Doctor News

- Advertisement -

Edinburg, Texas: DHR Health is proud to announce that it is the sponsoring institution for seven (7) newly accredited residencies and fellowships by the Accreditation Council for Graduate Medical Education (ACGME) totaling 107 accredited new residency and fellowship positions for the Rio Grande Valley. These programs will begin on July 1, 2023.  

Texas A&M Health had been invited to participate in these programs, with a Letter of Agreement signed March 20, 2023 between DHR Health and Texas A&M Health to work together on these new residencies.

DHR Health has learned today that Texas A&M Health is withdrawing from this agreement. DHR Health acknowledges this, and respects Texas A&M Health’s decision and wishes them well. 

- Advertisement -

DHR Health possesses all necessary resources, faculty and support to launch these excellent programs next month. These include the first-ever Emergency Medicine, Diagnostic Radiology and Surgical Critical Care Graduate Medical Education (GME) programs in the Rio Grande Valley, the only Urology residency in the RGV, and as well DHR Health’s own Internal Medicine, Family Medicine, and General Surgery residency programs.

DHR Health is committed to remain the leader for GME in the Rio Grande Valley, as a health system and now as an independent ACGME-accredited sponsor for our future physicians’ training programs.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Breakthrough TTFields Technology Gets FDA Approval for Pancreatic Cancer Treatment

Mega Doctor News The U.S. Food and Drug Administration has approved a...

El Paso Researchers Advance New Treatments for Cancer and Heart Disease

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India — a plant her grandmother used to treat everything from fevers to infections.

STHS Heart Celebrates 30 Years of Cardiovascular Excellence

On January 15, 1996, South Texas Health System (STHS) Heart—then named McAllen Heart Hospital—opened as one of the...

Unexpected Cancer Drug Combo Shows Stronger Results Against Ovarian Tumors

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better.
- Advertisement -
×